Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
1 other identifier
interventional
N/A
1 country
1
Brief Summary
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2007
CompletedFirst Posted
Study publicly available on registry
August 8, 2007
CompletedAugust 8, 2007
August 1, 2007
August 7, 2007
August 7, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
effect of furosemid inhalation on dyspnea
Interventions
Eligibility Criteria
You may qualify if:
- Patients with a history of exposure to sulfur mustard with a complaint of dyspnea
You may not qualify if:
- A contraindication for furosemide use;
- An accompanying disease in which other drugs effective for dyspnea were used
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RCCI
Tehran, Tehran Province, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mostafa Ghanei, MD
Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 7, 2007
First Posted
August 8, 2007
Last Updated
August 8, 2007
Record last verified: 2007-08